Tags : Biosimilars Switch Policy

Biosimilars

New Brunswick Government Introduces Biosimilars Switch Policy to Improve Patient

Shots: New Brunswick joins British Columbia and Alberta in implementing a “switch” policy that changes coverage for specific biologic medicines Patients switching from reference biologics to biosimilar versions will continue receiving safe, effective treatment and will enable to save millions of dollars once implemented Sandoz is committed to supporting patients, their HCPs, and the New […]Read More